MBX Biosciences (NasdaqGS:MBX) Conference September 30, 2025 10:00 AM ET Company ParticipantsSalomon Azoulay - CMOKent Hawryluk - CEOModeratorHi, good morning. It's our pleasure to have MBX Biosciences with us today, who is best known for its Precision Endocrine Peptide Canvuparatide for hypoparathyroidism, but they've also leveraged their program to various conditions in the cardiometabolic space. Specifically, they have MBX 1416, a GLP-1 antagonist for post-bariatric hypoglycemia, and also MBX 4291, which ...